Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma (Q41449151)

30 September 2017

title

Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma (English)

1 reference

30 September 2017

main subject

neoplastic stem cells

1 reference

Liang Zhu

1

1 reference

30 September 2017

Wei Zhang

series ordinal

2

1 reference

30 September 2017

Jianhua Wang

series ordinal

3

1 reference

30 September 2017

Rong Liu

series ordinal

4

1 reference

30 September 2017

publication date

12 February 2015

1 reference

30 September 2017

1 reference

30 September 2017

volume

36

1 reference

30 September 2017

issue

7

1 reference

30 September 2017

page(s)

5353-5360

1 reference

Novel therapeutic target for cancer stem cells in hepatocellular carcinoma

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Molecular mechanism of activating protein-4 regulated growth of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Expression of chemokine receptors on circulating tumor cells in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Stem cell dynamics and heterogeneity: implications for epidermal regeneration and skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Stem-cell hierarchy in skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Stem cell niche in tissue homeostasis, aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

CD44+CD133+population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Finding markers for cancer stem cells in renal cell carcinoma: Looking beyond CD133

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

The role of human aldehyde dehydrogenase in normal and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Proliferating pancreatic beta-cells upregulate ALDH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

ALDH expression characterizes G1-phase proliferating beta cells during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Identification of local and circulating cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

CD13 is a therapeutic target in human liver cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3196-6

Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor

21 January 2018

1 reference

12 December 2020

Identification of a cancer stem cell in human brain tumors

1 reference

12 December 2020

microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb

1 reference

12 December 2020

Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.

1 reference

12 December 2020

Standing out from the crowd: cancer stem cells in hepatocellular carcinoma

1 reference

12 December 2020

Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma

1 reference

12 December 2020

Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer.

1 reference

12 December 2020

10.1007/S13277-015-3196-6

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

1053193166

0 references

1 reference